We have examined all the US patents (444) issued to homegrown Indian pharma and pharma biotech firms. Most (425, 95%) patents are pharma patents not biotech (19). Also, only 11 patents have been cited ten times or more. This data provides one snapshot of the biotech industry in India today. It...

Market Menagerie examines technological advance and market regulation in the health industries of nations such as India, Brazil, South Africa, Nigeria, and Japan. Pharmaceutical and life science industries can reinforce economic development and industry growth, but not necessarily positive...

Market Menagerie addresses the tensions between economic and social policies. This book explores how states, markets, and other institutions interact within the health industry--using India as a primary case study.

India's healthcare industry : a system perspective / Lawton R. Burns -- Innovative responses to the healthcare challenges confronting India / Stephen M. Sammut -- India's healthcare industry : an overview of the value chain / Lawton R. Burns -- The medical profession in India / Ajay Bakshi,...

Most of the medicines available in market are generic in nature and has no valid patent. Their patent has either expired or not enforced. Therefore, any pharmaceutical or biotechnological company may take this as an opportunity to manufacture and sell such un-patented medicines in both national...